Stellantis NV Vs. Bright Minds Biosciences Industry Stock Comparison

Sell

15

STLA
Stellantis NV

Last Price:

$12.72

Seasonality Move:

-5.63%

Sell

25

DRUG
Bright Minds Biosciences

Last Price:

$37.50

Seasonality Move:

-32.13%

Sell

15

Stellantis NV (STLA) is a Sell

Is Stellantis NV a Buy, Sell or Hold?

The current Stellantis NV [STLA] share price is $12.56. The Score for STLA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
STLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

25

Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

The current Bright Minds Biosciences [DRUG] share price is $33.89. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

STLA Stock Price Chart

What is Stellantis NV's stock price today?

The Stellantis NV share price today is $12.56

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

The Bright Minds Biosciences share price today is $33.89

The current trend is relatively stagnant and DRUG is experiencing slight buying pressure.

STLA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.11	Buy
Relative Strength Index (14 RSI):	38.09	Sell
Chaikin Money Flow:	-16510711	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.92 - 13.82)	Sell
Bollinger Bands (100):	(12.81 - 13.65)	Sell

DRUG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.6	Sell
Relative Strength Index (14 RSI):	39.44	Sell
Chaikin Money Flow:	2596	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(31.9 - 42.16)	Sell
Bollinger Bands (100):	(23.98 - 48.72)	Sell

STLA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.76	Sell
20-day SMA:	13.38	Sell
50-day SMA:	13.16	Sell
200-day SMA:	15.95	Sell
8-day EMA:	13.46	Sell
20-day EMA:	13.42	Sell
50-day EMA:	13.34	Sell
200-day EMA:	15.6	Sell

DRUG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.31	Sell
20-day SMA:	38.38	Sell
50-day SMA:	37.75	Sell
200-day SMA:	18.73	Buy
8-day EMA:	36.19	Sell
20-day EMA:	37.52	Sell
50-day EMA:	37.1	Sell
200-day EMA:	24	Buy

Stellantis NV Earnings Growth & STLA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.68 per share, and a decrease next year of $0.22 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.

Stellantis NV Technical Analysis

	Feb 12	Feb 13	Feb 14	Feb 18	Feb 19	Feb 20	Feb 21	Feb 25	Feb 26	Feb 27
	Feb
	12	13	14	18	19	20	21	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

	Feb 12	Feb 13	Feb 14	Feb 18	Feb 19	Feb 20	Feb 21	Feb 25	Feb 26	Feb 27
	Feb
	12	13	14	18	19	20	21	25	26	27
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):